Aug 2025
At EHA in June 2025, the second edition of the EU CAR-T Playbook was released in collaboration by EBMT, EHA and the GoCART coalition.
The playbook highlights among other things the improvement in outcomes with CAR-T for patients with large B cell lymphoma (LBCL) who do not achieve durable remission with immunochemotherapy. This playbook aims at helping to define the patient population that should be offered CAR-T as the next line of treatment, providing a structured approach to improve patient outcomes.
